Why is Nidan Laborator. falling/rising?

As of 19-Sep, Nidan Laboratories & Healthcare Ltd is experiencing a decline in its stock price, currently at 19.10, which reflects a decrease of 0.3 or 1.55%. The stock has underperformed its sector today by 1.36%, and while it has shown a positive return of 2.96% over the past week, it has not improved over the past month, remaining flat at 0.00%. The stock's performance over the last year has been significantly negative, with a return of -43.49%, and its profits have also fallen by 40%. Additionally, the company has not declared results in the last six months, indicating weak long-term fundamental strength, and its ability to service debt is concerning due to a poor EBIT to Interest ratio of 1.75.
In the broader market context, the stock's short-term performance of +2.96% over the past week contrasts with the Sensex, which has only gained 0.85% in the same period. However, the stock has consistently underperformed against the benchmark over the last three years, with a staggering decline of -68.59% compared to the Sensex's gain of 43.72%. This persistent underperformance, coupled with a weak return on equity of 6.85%, suggests that investor confidence is waning, contributing to the stock's current downward trajectory.